AIMOVIG vs DEMI-REGROTON

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 23, 2026·How we rate

Possible drug interaction. AIMOVIG and DEMI-REGROTON are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AIMOVIG	DEMI-REGROTON
Rating	72/100	70/100
Pharmacy pays	—	~$2.67 /30
Type	RX	RX
Active ingredient	ERENUMAB-AOOE	CHLORTHALIDONE AND RESERPINE
Manufacturer	Amgen Inc	Sanofi Aventis US
Dosage forms	Injectable, Solution	Tablet
Drug class	—	—
Boxed warning	None	None
Half-life	—	about 40 hours on average (the label reports a mean half-life of 40 hours after a 50–200 mg dose, and an elimination half-life of 53 hours after 50 mg and 60 hours after 100 mg)

aimovig demi-regroton

Rating

72/100

70/100

Pharmacy pays

—

~$2.67 /30

Type

Active ingredient

ERENUMAB-AOOE

CHLORTHALIDONE AND RESERPINE

Manufacturer

Amgen Inc

Sanofi Aventis US

Dosage forms

Injectable, Solution

Tablet

Drug class

—

Boxed warning

None

Half-life

—

about 40 hours on average (the label reports a mean half-life of 40 hours after a 50–200 mg dose, and an elimination half-life of 53 hours after 50 mg and 60 hours after 100 mg)

Frequently asked questions

Which is better-rated, Aimovig or Demi-Regroton?

By our independent rating, Aimovig scores higher — 3.6 vs 3.5 out of 5 for Demi-Regroton. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Aimovig and Demi-Regroton?

Aimovig contains Erenumab-Aooe, while Demi-Regroton contains Chlorthalidone and Reserpine — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.